title: Treatment of lung cancer: will financial issues become a criterion of choice?
authors.forename: Alain
authors.initials: A
authors.lastname: Vergnenegre
authors.forename: Isabelle
authors.initials: I
authors.lastname: Borget
authors.forename: Christos
authors.initials: C
authors.lastname: Chouaid
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D005060:Europe; D017048:Health Care Costs; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics; D008962:Models, Theoretical; D058990:Molecular Targeted Therapy / Q000191:economics; D014481:United States
chemical_list: D000970:Antineoplastic Agents